Bergur V. Stefánsson

Also affiliated with AstraZeneca (Finland), AstraZeneca (Sweden), AstraZeneca (Spain), AstraZeneca (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL”.

POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

Kidney International Reports(2021)10.1016/j.ekir.2021.03.869

N/A

0DataRank · unranked

3 citations

Priya Vart, Niels Jongs, Robert D. Toto, José Luis Górriz, Fan Fan Hou +9 more